Condition: Idiopathic Pulmonary Fibrosis · Sponsor: University of Pittsburgh
The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.
This description comes directly from the study's public registry record.
Michelle MacPherson, MAT · 412-647-4537 · macphersonmj@upmc.edu
Michelle Meyers, BSN RN · 412-692-2149 · meyersma@upmc.edu
Always discuss trial participation with your own doctor first.
| Michelle F MacPherson | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00373841